Yestar Healthcare Plans Joint Venture to Expand Precision Oncology Services in Southeast Asia
I'm PortAI, I can summarize articles.
Yestar Healthcare Holdings Co Ltd plans to form a joint venture with New Genetron Holding Limited in Singapore to establish clinical molecular diagnostics laboratories in Indonesia. This initiative aims to enhance precision oncology services, including early cancer screening and genomic profiling, utilizing Genetron Health’s technology. The venture is expected to strengthen Yestar’s market presence in Southeast Asia and foster collaborations with Indonesian healthcare institutions. Yestar is involved in distributing IVD products and manufacturing medical imaging films in China, with a current market cap of HK$295.9M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments